Symbols

ARWR

Arrowhead Pharmaceuticals·NASDAQ

--(--)

ARWR Filings

2026-03-20 · Key Events

Form 8-K - Current report

2026-03-09 · Ownership

Form 4 - Statement of changes in beneficial ownership of securities

2026-03-05 · Ownership

Form 144 - Report of proposed sale of securities

2026-02-05 · Earnings Call

Arrowhead Pharmaceuticals, Inc. (ARWR) Q1 2026 Earnings Call Transcript

2026-02-05 · Financials

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

2026-02-05 · Key Events

Form 8-K - Current report

2026-01-27 ·

Form ARS - Annual Report to Security Holders

2026-01-27 · Key Events

Form DEF 14A - Other definitive proxy statements

2026-01-27 · Key Events

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

2026-01-21 ·

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]